Navigation Links
Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer
Date:1/17/2008

Former Electrophysiologist at Cleveland Clinic Brings Extensive Experience in the Use of Interventional Magnetic Navigation Systems in the Treatment

of Cardiovascular Disease

ST. LOUIS, Jan. 17 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today the appointment of J. David Burkhardt, M.D., F.A.C.C., as Chief Medical Officer. Dr. Burkhardt was most recently the Associate Program Director for the Clinical Cardiac Electrophysiology Fellowship training program and he directed the Clinical Electrophysiology curriculum at the Lerner Case Western Reserve School of Medicine at the Cleveland Clinic.

"We are very pleased that David has joined the Stereotaxis executive team," said Bevil J. Hogg, Chief Executive Officer of Stereotaxis. "He is renowned in the field of cardiac electrophysiology and has extensive experience in the use of robotic navigation systems, including the Stereotaxis Niobe System. Through his authorship of numerous peer-reviewed publications and abstracts, as well as speaking engagements at professional conferences worldwide, David has established himself as an expert in his field. He brings a much-valued perspective as a practicing cardiac electrophysiologist to Stereotaxis' mission to provide the safest, most effective standard of care in the treatment of cardiac arrhythmias."

"I am thrilled to be joining Stereotaxis at this very important time, with the FDA approval of the irrigated tip catheter," said Dr. Burkhardt. "While at the Cleveland Clinic, I had the opportunity to evaluate several new technologies, and performed more than 300 cases with the Stereotaxis Niobe System. I believe that Stereotaxis has the ability to revolutionize the way electrophysiology and interventional procedures are performed."

Dr. Burkhardt is board certified in Internal Medicine, Cardiovascular Medicine and Clinical Cardiac Electrophysiology. He received his Bachelor's and Medical degrees from
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
2. Stereotaxis Announces FDA Approval of Its Partnered Magnetic Irrigated Catheter
3. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
4. Codexis Appoints Singapore Laboratories Managing Director
5. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
9. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. NeurogesX Appoints New Director to the Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...nt(R) Miniature Brachytherapy X-ray Source as One,...ducts of the Past Year, SUNNYVALE, Calif., July 2...the Axxent(R) High Dose Rate (HDR) X-ray Source ha...&D Magazine as one of the year,s most,technologica...rs of R&D,Magazine in 1963, the R&D 100 Awards are...
(Date:7/24/2008)... 24 /- Sagent Pharmaceuticals, Inc.,... today announced that it,has launched ceftazidime ..., beta-lactam antibiotic. Sagent will offer ceftaz...y bulk package vials. According to,IMS data, 2007 ...s were,approximately $45.7 million., "Sagent is p...
(Date:7/24/2008)...4 /- Human Genome,Sciences,...P. Southwell has,been appointed to the HGS Board o... Company,s Audit Committee. Until recently, Mr. So...armaceutical company, where he served,as Executive...lso had,responsibility for Corporate Planning, Dev...
(Date:7/23/2008)...nology will significantly change virtually every f...the opportunity to shape these changes and to ensu...d and its risks identified and controlled. A new r...avies lays out a clear roadmap for the next presid...and longer term steps necessary to deal with the c...
Breaking Biology Technology:Xoft Recognized With R&D 100 Award 2Xoft Recognized With R&D 100 Award 3Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP 2Human Genome Sciences Appoints David P. Southwell to its Board of Directors 2Human Genome Sciences Appoints David P. Southwell to its Board of Directors 3Human Genome Sciences Appoints David P. Southwell to its Board of Directors 4Nanotech: A regulatory blueprint for the next administration 2
..., Achieving Ultra Fast Liquid Chromatograph...een designed to achieve,Ultra-Fast HPLC by utili...pect, we are successful,in demonstrating high sp... to high pressure, while providing high,reliabil...t,LC systems., Smaller particle columns ...
...T.J. Higley and Roy Eksteen, Tosoh Bioscience LLC,... Lexigen Pharmaceuticals, Lexington, Massachusetts...uring method development, many variables are exami...s such as elution profile, peak shape, and recover...GLP protocols. During a recent method , r...
..., Introduction , It is well k...icles are , more efficient at the expense... packed with larger particles. The gain in ef...ing column length, which in turn results in shorte...pressure. , Recently, two lines of 5 micro...
... Key words: Amino Acids, RP-HPLC, Precolumn deri...pionic acid, Ultraviolet detection., , ...cids do not significantly absorb light in the UV/..., their analysis normally includes a derivatisati...cursor to yield a strong UV/Visible chromophore or...
Other Biology Technology:Prominence UFLC 2Prominence UFLC 3Prominence UFLC 4Prominence UFLC 5Prominence UFLC 6Prominence UFLC 7Prominence UFLC 8Mobile Phase Optimization for the Analysis of an Antibody-Based Fusion Protein and Aggregates using a TSKgel Super SW3000 Size-Exclusion Column 2Mobile Phase Optimization for the Analysis of an Antibody-Based Fusion Protein and Aggregates using a TSKgel Super SW3000 Size-Exclusion Column 3Three Micron TSK-GEL ODS-100V Columns for High Throughput LCMS 2ANALYSIS OF AMINO ACIDS BY REVERSED PHASE CHROMATOGRAPHY WITH PRECOLUMN DERIVATISATION AND UV/VISIBLE DETECTION 2ANALYSIS OF AMINO ACIDS BY REVERSED PHASE CHROMATOGRAPHY WITH PRECOLUMN DERIVATISATION AND UV/VISIBLE DETECTION 3
(Date:7/23/2008)...y 24, 2008 One of the reasons people on low-carbo...their intake of fructose, a type of sugar that can...earcher at UT Southwestern Medical Center. , D...l nutrition and lead author of a study appearing i...aid her team,s findings suggest that the right typ...
(Date:7/23/2008)... parasites living in three estuaries on the Pacifi...hers have determined that biomass of these parasit... more than 20 times. , Their findings, which cou...ications, appear in this week,s issue of the journ...atter that exists in a given habitat. It is expres...
(Date:7/23/2008)... recent study shows that popular fish oil suppleme..., acute wounds in human skin. But whether that eff...cted, remains a mystery. , The omega-3 fatty aci...efit cardiovascular health and other diseases rela...inflammatory properties. But insufficient inflamma...
(Date:7/23/2008)...alif.) - In a study of free-living and parasitic s...California and Baja California, a team of research...ra, the United States Geological Survey, and Princ...ss in those habitats exceeds that of top predators... which could have significant biomedical and ecolo...
Breaking Biology News(10 mins):Limiting fructose may boost weight loss, UT Southwestern researcher reports 2Limiting fructose may boost weight loss, UT Southwestern researcher reports 3Parasites outweigh predators in Pacific Coast estuaries 2Parasites outweigh predators in Pacific Coast estuaries 3Scientists suspect omega-3 fatty acids could slow acute wound healing 2Scientists suspect omega-3 fatty acids could slow acute wound healing 3Scientists suspect omega-3 fatty acids could slow acute wound healing 4Study shows parasites outweigh predators 2Study shows parasites outweigh predators 3Results of TRIUMPH 1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday November 1 2007 711 1Results of TRIUMPH 1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday November 1 2007 711 2Health Insurance Agents Warn Against Imposing a Health Care Reform Tax in California 5163 1Health Insurance Agents Warn Against Imposing a Health Care Reform Tax in California 5163 2Health Insurance Agents Warn Against Imposing a Health Care Reform Tax in California 5163 3Boston Scientific Announces Verdict in Cordis Litigation 5159 1Boston Scientific Announces Verdict in Cordis Litigation 5159 2Boston Scientific Announces Verdict in Cordis Litigation 5159 3Diverse Partners Renew Commitment to Reproductive Health Rights in Asia 5155 1Diverse Partners Renew Commitment to Reproductive Health Rights in Asia 5155 2Diverse Partners Renew Commitment to Reproductive Health Rights in Asia 5155 3
...alaria remains the subject of "best guesses," and ...l remains "driven by perceptions and politics, rat... prominent malaria researchers in PLoS Medicine. ,... Institute and University of Oxford), say that it ... of malaria endemicity was constructed, and that "...
...an be arranged along a ladder of intelligence—a so...bly at the top, followed by our close relatives, t...imy creatures. Over the past decade, this ladder h...and great social complexity in other animals. For ...hich dominant females support the rank contests of...
... fight viruses is also involved in keeping cancer ...l Center have discovered. , The anti-viral molecu...ncer cells to live, so blocking it might point to ...eport in today,s issue of Cell. , "We got the s...cell survival, even though it,s normally involved ...
...into a new life, or into new cells that may someda...in the mechanics - in how a single cell can transf...versity report this week in the Proceedings of the...tified genes unique to the human egg. The identifi... functions, which may lead to solving problems fro...
Other Biology News:Fishy cooperation 2Natural anti-viral enzyme helps keep cancer cells alive, researchers find 2Scientists crack genetic secrets of human egg 2